Tibor Keler, Executive VP & CSO at Celldex Therapeutics, Inc. (CLDX), bought 5,000 shares at $2.99 ($15K) on 2020-06-09, disclosed to the SEC on 2020-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CLDX | BUY | 2016-09-06 | $10K | — | Filing → |
| CLDX | BUY | 2011-08-11 | $13K | — | Filing → |
| CLDX | BUY | 2010-09-13 | $18K | — | Filing → |